The Revised Common Rule: Changes for Human Subjects Researchers

Health and Human Services logo

Office for Research Protections     |     Institutional Review Board (IRB)

The federal policies mandating the protection of human subjects are known as the “Common Rule,” and on January 21, 2019, a substantial revision to the Common Rule will take effect. These changes are meant to ease some researcher burden while enhancing the protection of human subjects. These changes apply only to new studies submitted on or after January 21, 2019. Please note: the revised Common Rule does NOT apply to FDA-regulated and Department of Justice studies.

Recommendations for Researchers

The Office for Research Protections is working to implement the revised Common Rule changes, and no action is required by researchers at this time. However, it’s important to note that researchers submitting their studies to the IRB on or after January 21, 2019 will be reviewed under the revised Common Rule. If you have flexibility in the timing of your study and are starting a new study, we recommend waiting to submit on or after January 21 to have your study reviewed under the revised Common Rule. New templates to use for review under the revised Common Rule will be available later this year. Alternately, you may want to submit well in advance of January 21 to be reviewed under the current regulations; submissions to the IRB often require revisions that take time, and we want to help researchers avoid being caught in Common Rule "limbo." We are continuing to evaluate whether, in the future, we will apply the revised Common Rule to studies existing prior to January 21.

Common Rule Changes: Highlights

Of particular interest to many Penn State researchers are changes in three areas: expanded exemption categories, continuing review changes, and consent form changes. Below are a few highlights regarding the changes in these areas. 

New Exempt Categories

The Common Rule defines three levels of review for human subjects research: exempt, expedited, and full (committee). The new Common Rule broadens the types of research that may be determined to be exempt from IRB review. For example, starting January 21, benign behavioral interventions conducted with adults may be determined to be exempt. Researchers must submit to the IRB program for a determination that activities are exempt from IRB review. Another example: the collection of identifiable, sensitive information from adults may also be exempt; however, this new category requires a limited IRB review to determine that appropriate privacy and confidentiality protections are in place.  

Continuing Review Changes

Some minimal risk studies will no longer be required to renew their IRB approval on an annual basis (continuing review). Investigators conducting eligible studies will be informed of post-approval requirements at the time of initial approval.  

Consent Form Changes

Consent forms will need to include a brief summary that explains the research to potential participants in an easy-to-understand and clear manner. It is now mandated that consent forms be concise while also giving the full context of a study, including its risks and benefits, so potential participants have all the information they need to make an informed decision. Consent forms will also need to include information regarding the potential for future use of de-identified data and biospecimens. 

In addition, there is a new requirement that cooperative research studies involving more than one institution to use a single IRB for review. The implementation date for this requirement is January 19, 2020. 

Learn More

For updates related to the Common Rule or to learn more about the changes, visit our Common Rule and Other Changes page.

Attend IRB 101 Series*: New IRB Requirements for 2019—Revised Common Rule on November 29 from 12-1 PM in 102 Kern.